Medicine and Dentistry
Patient
100%
Therapeutic Procedure
56%
Glomerulopathy
40%
Spontaneous Remission
39%
Membranous Glomerulonephritis
34%
Autoantibody
33%
Disease
33%
Inpatient
33%
Glomerulonephritis
32%
Vasculitis
30%
ANCA Associated Vasculitis
29%
Small Vessel Vasculitis
29%
Nephrotic Syndrome
28%
Combination Therapy
28%
Nephropathy
23%
Proteinuria
23%
End Stage Renal Disease
22%
Adult
22%
Rituximab
21%
Relapse
20%
Focal Segmental Glomerulosclerosis
20%
Immunoglobulin A Nephropathy
17%
Neutrophil
15%
Myeloperoxidase
14%
Diagnosis
14%
Neutrophil Cytoplasmic Antibody
14%
Child
14%
Renal Biopsy
13%
Association
12%
Microscopic Polyangiitis
12%
Predictor
12%
Hazard Ratio
11%
B Cell
10%
Quality of Life
10%
Biopsy
10%
Creatinine
10%
Immunosuppressive Treatment
10%
Myeloblastin
10%
Kidney Function
10%
Pathogenesis
9%
Thromboembolism
9%
Patient-Reported Outcome
9%
Analysis
8%
Kidney
8%
Health
8%
Serum Albumin
8%
Infection
8%
Adverse Event
8%
Lupus Nephritis
8%
Disease Activity
7%
Immunology and Microbiology
Vasculitis
35%
Autoantibodies
35%
ANCA Associated Vasculitis
20%
Glomerulonephritis
20%
Neutrophil Cytoplasmic Antibody
19%
Neutrophil Granulocyte
18%
Kidney
11%
Mouse
10%
Monospecific Antibody
10%
Time
10%
Rituximab
9%
IgA Nephropathy
8%
B Cell
7%
Glucocorticoid
6%
Antigen
6%
Transplantation
6%
Gene
6%
Microscopic Polyangiitis
5%
Nursing and Health Professions
Patient
26%
Remission
10%
Adult
9%
Small Vessel Vasculitis
9%
Quality of Life
8%
Diseases
8%
Glomerulopathy
7%
Patient-Reported Outcome
7%
Time
7%
Child
7%
Neutrophil Cytoplasmic Antibody
7%
Membranous Glomerulonephritis
6%
Focal Glomerulosclerosis
6%
Confidence Interval
6%
Autoantibody
6%
Nephrotic Syndrome
6%
End Stage Renal Disease
6%
Hazard Ratio
5%
Combination Therapy
5%
Survival
5%
Outcome Assessment
5%
